Results 171 to 180 of about 36,039 (270)
Prophylactic folinic acid prevents pemetrexed myelosuppression: A randomized trial toward safer treatment with chemotherapy in non-small cell lung cancer. [PDF]
Contrucci R +8 more
europepmc +1 more source
ABSTRACT Patients with high‐risk acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) continue to face a substantial risk of relapse after allogeneic hematopoietic stem cell transplantation (allo‐HSCT), which remains a leading cause of treatment failure.
Cuicui Lyu +6 more
wiley +1 more source
Prognostic value of the three-lineage cytopenia score in locally advanced nasopharyngeal carcinoma: A retrospective cohort study. [PDF]
Li Y, Li Z, He J, Li Y, Duan Y, Yang D.
europepmc +1 more source
ABSTRACT Background and Aims Thalassemia is an inherited hemoglobin disorder characterized by ineffective erythropoiesis, chronic anemia, and progressive multisystem complications that require lifelong management. Current treatment relies on regular red blood cell transfusions, iron chelation therapy, and supportive multidisciplinary care, while ...
Fnu Zainab +3 more
wiley +1 more source
Severe Thiopurine-Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report. [PDF]
Fry J +10 more
europepmc +1 more source
Abstract Recent advances in cancer screening, diagnosis, and treatment have greatly improved survival rates among women with gynecologic cancers. More survivors now live long enough to experience treatment‐related menopause. Vasomotor symptoms, genitourinary syndrome of menopause, sexual dysfunction, sleep issues, and long‐term risks from estrogen ...
Agnaldo Lopes da Silva‐Filho +8 more
wiley +1 more source
Intrathecal chemotherapy for leptomeningeal metastasis of non-small-cell lung cancer: a systematic review. [PDF]
Wang D +5 more
europepmc +1 more source
Immunotherapy With Anti‐PD‐1 Versus Anti‐PD‐L1 in SCLC: A Comprehensive Retrospective Analysis
1. Both PD‐1 and PD‐L1 inhibitors significantly improved overall survival (OS) and progression‐free survival (PFS). 2. Younger patients (aged < 65 years) who received radiotherapy or those with limited‐stage SCLC may be the preferred population for anti‐PD‐1 treatment in SCLC .
Ruiyuan Yang +4 more
wiley +1 more source
We report a proof‐of‐concept combination of topoisomerase inhibition and FLASH radiotherapy showing enhanced antitumor activity in head and neck carcinoma biomodels, supporting further investigation of this strategy in more clinically representative models and treatment settings. ABSTRACT Locally advanced head and neck carcinoma remains associated with
Patrizia Sarogni +17 more
wiley +1 more source
Leptomeningeal metastasis (LM), an uncommon yet highly fatal condition, involves malignant tumor infiltration of the meninges resulting in progressive neurological deterioration and severe quality‐of‐life impairment. LM remains largely refractory to treatment and lacks standardized treatment consensus, with a low intracranial objective response rate ...
Wenbin Zhou +10 more
wiley +1 more source

